EVIDENCE GAP ANALYSIS OF THE BURDEN OF ILLNESS AND TREATMENT OF MYASTHENIA GRAVIS

被引：0
|
作者：
Copley-Merriman, K. [1 ]
Miller-Wilson, L. A. [2 ]
Costello, J. [3 ]
Schwinn, J. [4 ]
Edwards, Y. [4 ]
机构：
[1] RTI Hlth Solut, Ann Arbor, MI USA
[2] Immunovant Inc, Montgomery, TX USA
[3] RTI Hlth Solut, Manchester, Lancs, England
[4] Immunovant Inc, New York, NY USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD138
引用
收藏
页码：S384 / S385
页数：2
相关论文
共 50 条
  • [1] EVIDENCE GAP ANALYSIS OF THE BURDEN OF DISEASE AND TREATMENT OF MYASTHENIA GRAVIS
    Copley-Merriman, Kati
    Miller-Wilson, Lesley-Ann
    Costello, Jessica
    Schwinn, Jennifer
    Edwards, Yuriy
    MUSCLE & NERVE, 2024, 70 (03) : 644 - 644
  • [2] Burden of illness in patients with treatment refractory myasthenia gravis
    Engel-Nitz, Nicole M.
    Boscoe, Audra
    Wolbeck, Ryan
    Johnson, Jonathan
    Silvestri, Nicholas J.
    MUSCLE & NERVE, 2018, 58 (01) : 99 - 105
  • [3] EVIDENCE GAP ANALYSIS OF THE BURDEN OF ILLNESS AND TREATMENT OF BULLOUS PEMPHIGOID
    Gildea, L.
    Copley-Merriman, K.
    Arvin-Berod, C.
    Vande Walle, K.
    Verheesen, P.
    Stoykov, I
    VALUE IN HEALTH, 2023, 26 (12) : S27 - S27
  • [4] EVIDENCE GAP ANALYSIS OF THE BURDEN OF ILLNESS AND TREATMENT OF PEMPHIGUS VULGARIS AND FOLIACEUS
    Copley-Merriman, C.
    D'Souza, V
    Arvin-Berod, C.
    Phillips, G.
    Verheesen, P.
    Heyerick, A.
    Stoykov, I
    VALUE IN HEALTH, 2022, 25 (12) : S41 - S41
  • [5] EVIDENCE GAP ANALYSIS OF THE BURDEN OF ILLNESS AND TREATMENT OF PRIMARY IMMUNE THROMBOCYTOPENIA
    Yang, J.
    Masaquel, C.
    Arvin-Berod, C.
    Phillips, G.
    Godar, M.
    Desai, M.
    Ayguasanosa, J.
    VALUE IN HEALTH, 2022, 25 (12) : S19 - S19
  • [6] EVIDENCE GAP ANALYSIS OF THE BURDEN OF ILLNESS AND TREATMENT OF THYROID EYE DISEASE
    Gildea, L.
    Arvin-Berod, C.
    Heyes, A.
    Heyerick, A.
    Urdaniz, E.
    Vainilovich, Y.
    Trainor, L.
    Densmore, D.
    VALUE IN HEALTH, 2024, 27 (06) : S35 - S35
  • [7] Burden of illness and costs in patients with myasthenia gravis currently receiving treatment in the United States
    Parthan, A.
    Royston, M.
    Thanataveerat, A.
    East, E. L.
    Parzynski, C. S.
    Habib, A. A.
    MUSCLE & NERVE, 2024, 69 (02) : 157 - 165
  • [8] EVIDENCE GAP ANALYSIS OF THE BURDEN OF ILLNESS AND TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
    Copley-Merriman, C.
    Arvin-Berod, C.
    Phillips, G.
    Gelinas, D.
    Weiss, R.
    Hofman, E.
    Tse, A.
    VALUE IN HEALTH, 2022, 25 (12) : S34 - S34
  • [9] A COST-OF-ILLNESS ANALYSIS OF MYASTHENIA GRAVIS IN GREECE
    Athanasakis, K.
    Glava, V
    Zacharis, M.
    Zouvelou, V
    Evdokimidis, I
    Kyriopoulos, J.
    VALUE IN HEALTH, 2011, 14 (07) : A321 - A321
  • [10] Socio-Economic Burden of Myasthenia Gravis: A Cost-of-Illness Study in Bulgaria
    Ignatova, Valentina
    Kostadinov, Kostadin
    Vassileva, Evguenia
    Muradyan, Naira
    Stefanov, Georgi
    Iskrov, Georgi
    Stefanov, Rumen
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
12345